These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 21062616)

  • 1. Use of clinical markers to identify metabolic syndrome in antipsychotic-treated patients.
    Jin H; Meyer J; Mudaliar S; Henry R; Khandrika S; Glorioso DK; Kraemer H; Jeste D
    J Clin Psychiatry; 2010 Oct; 71(10):1273-8. PubMed ID: 21062616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
    Mojiminiyi OA; Abdella NA; Al Arouj M; Ben Nakhi A
    Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
    Hung J; McQuillan BM; Thompson PL; Beilby JP
    Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Easy and low-cost identification of metabolic syndrome in patients treated with second-generation antipsychotics: artificial neural network and logistic regression models.
    Lin CC; Bai YM; Chen JY; Hwang TJ; Chen TT; Chiu HW; Li YC
    J Clin Psychiatry; 2010 Mar; 71(3):225-34. PubMed ID: 19814949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of serum levels of leptin, ghrelin, and adiponectin in schizophrenic patients and healthy controls.
    Tsai MC; Chang CM; Liu CY; Chang PY; Huang TL
    Int J Psychiatry Clin Pract; 2011 Jun; 15(2):106-11. PubMed ID: 22121858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delusion of pregnancy associated with antipsychotic induced metabolic syndrome.
    Manjunatha N; Saddichha S
    World J Biol Psychiatry; 2009; 10(4 Pt 2):669-70. PubMed ID: 19096992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic effects of rosiglitazone in nondiabetic patients with metabolic syndrome.
    Aquilante CL; Kosmiski LA; Zineh I; Rome LC; Knutsen SD
    Pharmacotherapy; 2010 Mar; 30(3):236-47. PubMed ID: 20180607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls.
    Elmslie JL; Porter RJ; Joyce PR; Hunt PJ; Shand BI; Scott RS
    Aust N Z J Psychiatry; 2009 Jan; 43(1):53-60. PubMed ID: 19085528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between pulse wave velocity and metabolic syndrome and adiponectin in patients with impaired fasting glucose: cardiovascular risks and adiponectin in IFG.
    Nam JS; Park JS; Cho MH; Jee SH; Lee HS; Ahn CW; Lowe WL; Kim KR
    Diabetes Res Clin Pract; 2009 May; 84(2):145-51. PubMed ID: 19261346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of indices of insulin resistance with metabolic syndrome classifications to predict the development of impaired fasting glucose in overweight and obese subjects: a 3-year prospective study.
    Shand BI; Scott RS; Lewis JG; Elder PA; Frampton CM
    Int J Obes (Lond); 2009 Nov; 33(11):1274-9. PubMed ID: 19721448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risks of CHD identified by different criteria of metabolic syndrome and related changes of adipocytokines in elderly postmenopausal women.
    Ding QF; Hayashi T; Zhang XJ; Funami J; Ge L; Li J; Huang XL; Cao L; Zhang J; Akihisa I
    J Diabetes Complications; 2007; 21(5):315-9. PubMed ID: 17825756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Menopause impacts the relation of plasma adiponectin levels with the metabolic syndrome.
    Henneman P; Janssens AC; Zillikens MC; Frolich M; Frants RR; Oostra BA; van Duijn CM; van Dijk KW
    J Intern Med; 2010 Apr; 267(4):402-9. PubMed ID: 19912464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, resistin, and ghrelin.
    Chu MC; Cosper P; Orio F; Carmina E; Lobo RA
    Am J Obstet Gynecol; 2006 Jan; 194(1):100-4. PubMed ID: 16389017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptin, adiponectin, leptin to adiponectin ratio and insulin resistance in depressive women.
    Zeman M; Jirak R; Jachymova M; Vecka M; Tvrzicka E; Zak A
    Neuro Endocrinol Lett; 2009; 30(3):387-95. PubMed ID: 19855365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microvascular function, metabolic syndrome, and novel risk factor status in women with cardiac syndrome X.
    Jadhav ST; Ferrell WR; Petrie JR; Scherbakova O; Greer IA; Cobbe SM; Sattar N
    Am J Cardiol; 2006 Jun; 97(12):1727-31. PubMed ID: 16765122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
    Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T
    J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum uric acid and leptin levels in metabolic syndrome: a quandary over the role of uric acid.
    Lin JD; Chiou WK; Chang HY; Liu FH; Weng HF
    Metabolism; 2007 Jun; 56(6):751-6. PubMed ID: 17512306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adiponectin is an important determinant of apoA-I catabolism.
    Vergès B; Petit JM; Duvillard L; Dautin G; Florentin E; Galland F; Gambert P
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1364-9. PubMed ID: 16574896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum adiponectin as a useful marker for metabolic syndrome in type 2 diabetic patients.
    Yun JE; Sull JW; Lee HY; Park E; Kim S; Jo J; Lee SJ; Kim SY; Choi YJ; Jee SH; Huh KB
    Diabetes Metab Res Rev; 2009 Mar; 25(3):259-65. PubMed ID: 19214966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Waist circumference as a screening tool for the identification of adolescents with the metabolic syndrome phenotype.
    Bitsori M; Linardakis M; Tabakaki M; Kafatos A
    Int J Pediatr Obes; 2009; 4(4):325-31. PubMed ID: 19922048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.